Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 417,045 | 170,668 | 781,643 | 655,028 | 490,334 |
| Depreciation Amortization | 361,743 | 178,071 | 732,602 | 538,534 | 344,120 |
| Income taxes - deferred | -16,178 | -3,621 | -75,669 | -35,637 | 9,069 |
| Accounts receivable | 141,503 | 81,850 | -148,394 | -135,632 | -132,043 |
| Accounts payable and accrued liabilities | -40,615 | -20,535 | 87,481 | 38,870 | 24,517 |
| Other Working Capital | 78,314 | 83,158 | 101 | -30,599 | -350,548 |
| Other Operating Activity | -29,148 | -27,034 | 186,806 | 190,284 | 124,867 |
| Operating Cash Flow | $912,664 | $462,557 | $1,564,570 | $1,220,848 | $510,316 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,912 | 45,615 | -58,487 | -57,264 | -80,350 |
| PPE Investments | -251,006 | -134,231 | -603,429 | -409,391 | -150,632 |
| Net Acquisitions | -2,575 | N/A | -57,308 | 72,277 | -9,491 |
| Purchase Of Investment | -178,922 | -32,904 | -31,885 | -28,176 | -23,806 |
| Sale Of Investment | N/A | 3,856 | N/A | 3,763 | N/A |
| Purchase Sale Intangibles | N/A | N/A | 117,582 | N/A | N/A |
| Other Investing Activity | 1,758 | 1,120 | 120,762 | 1,708 | 1,047 |
| Investing Cash Flow | $-463,657 | $-116,544 | $-630,347 | $-417,083 | $-263,232 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,136,873 | 611,829 | 2,393,116 | 1,705,913 | 1,182,911 |
| Debt Repayment | -2,347,120 | -880,552 | -2,404,395 | -1,557,358 | -841,687 |
| Common Stock Issued | -43,612 | -7,902 | 18,577 | -42,248 | -47,866 |
| Common Stock Repurchased | N/A | N/A | -802,228 | -802,228 | -617,432 |
| Other Financing Activity | -118,889 | 713 | -326,198 | -194,307 | -120,891 |
| Financing Cash Flow | $-372,748 | $-275,912 | $-1,121,128 | $-890,228 | $-444,965 |
| Exchange Rate Effect | 6,922 | 2,307 | -29,066 | -6,283 | -1,342 |
| Beginning Cash Position | 338,989 | 338,989 | 554,960 | 554,960 | 554,960 |
| End Cash Position | 422,170 | 411,397 | 338,989 | 462,214 | 355,737 |
| Net Cash Flow | $83,181 | $72,408 | $-215,971 | $-92,746 | $-199,223 |
| Free Cash Flow | |||||
| Operating Cash Flow | 912,664 | 462,557 | 1,564,570 | 1,220,848 | 510,316 |
| Capital Expenditure | -272,204 | -147,705 | -603,429 | -409,391 | -265,461 |
| Free Cash Flow | 640,460 | 314,852 | 961,141 | 811,457 | 244,855 |